Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alan Fuhrman currently holds 16,164 shares of SpringWorks Therapeutics, Inc. (SWTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alan Fuhrman has been a net seller of SWTX stock. They have purchased $0 and sold $467.4K worth of shares.
Alan Fuhrman's most recent insider trade was on Mar 13, 2026, when they sold 1,376 shares at $9.13 per share.
Alan Fuhrman serves as Executive at SpringWorks Therapeutics, Inc. (SWTX). They have executed 21 insider transactions totaling $467.4K over their tenure at the company.
Alan Fuhrman holds the position of Executive at SpringWorks Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Alan Fuhrman has shown a selling trading pattern, with $0 in total purchases and $467.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Alan Fuhrman was on Jun 8, 2018, when they sold $467.4K worth of LOXO shares. This transaction involved 2,625 shares at $178.07 per share.
Alan Fuhrman currently owns 16,164 shares of SpringWorks Therapeutics, Inc. (SWTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alan Fuhrman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alan Fuhrman has 21 Form 4 filings on record as an insider at SpringWorks Therapeutics, Inc..
Set alerts for Alan Fuhrman and 40,000+ other insiders.